{"article_id": "UNH_q4_2021.txt", "article": ["these , and the broader performance across the enterprise , confirm our confidence in our ability to advance our stated growth strategies and to support our long - term 13 % to 16 % earnings per share growth rate .", "taken together , these efforts helped us add more than $ 30 billion in revenue for the year , about $ 10 billion above our initial outlook .", "as an example , in ' 21 , we incurred over $ 100 million in preparation expense .", "activity over the past several weeks shows primary care visits having declined about 10 % and an even higher rate of decline in specialist visits .", "optumhealth 's revenue per consumer grew by over 30 % in ' 21 , driven by the increasing number of our patients served under value - based arrangements .", "consistent with the expectations we shared in late november , we had a strong start to the year and continue to expect to add 500,000 new patients in accountable value - based relationships , benefiting from the groundwork laid over the past many years .", "optuminsight 's earnings grew 25 % in ' 21 , with operating margins approaching 28 % for the year .", "we ended the year with a revenue backlog of $ 22.4 billion , an increase of $ 2.2 billion over the prior year .", "optumrx earnings grew 6 % for the year , driven by the continued expansion of our pharmacy services businesses , supply chain initiatives and strong cost management activities and benefiting from strong customer retention .", "full - year revenues of $ 223 billion grew 11 % .", "within the up to 800,000 new members we will serve in ' 22 , about three - quarters will be in individual and group medicare advantage and the remainder in dual special needs plans .", "over the course of the year , we will look to continue to expand upon the nearly 8 million individuals we serve across 31 states .", "we concluded ' 21 with commercial membership about 200,000 people ahead of the original outlook provided .", "full year ' 21 cash flow from operations was $ 22.3 billion or 1.3 times net income , about $ 2 billion above the initial outlook we shared a year ago .", "we continue to expect our 2022 cash flow to approach $ 24 billion , about 1.2 times net income .", "and we ended ' 21 with a debt - to - total capital ratio of 38 % .", "these ample capital capacities allow us to continue to accelerate our investments , while remaining committed to an advancing shareholder dividend and supporting our expected repurchase of between $ 5 billion and $ 6 billion of stock in ' 22 .", "our 2022 adjusted earnings per share outlook of $ 21.10 to $ 21.60 is consistent with the view we offered seven weeks ago .", "from this distance , and in contrast to the past two years , we expect the seasonal pattern to be more consistent with our historical experience , with just under 50 % of full - year earnings in the first half and the first two quarters comparably even ."], "summary_gold": "affirmed 2022 growth and performance objectives established at its november 30 , 2021 investor conference .<q>unitedhealth - confirmed 2022 growth forecast elements provided at its investor conference , including for people served through medicare advantage .<q>unitedhealth - cash flows from operations for the full year 2021 were $ 22.3 billion or 1.3 x times net income .", "summary_pred": "full year ' 21 cash flow from operations was $ 22.3 billion or 1.3 times net income , about $ 2 billion above the initial outlook we shared a year ago .<q>activity over the past several weeks shows primary care visits having declined about 10 % and an even higher rate of decline in specialist visits .<q>our 2022 adjusted earnings per share outlook of $ 21.10 to $ 21.60 is consistent with the view we offered seven weeks ago .<q>we concluded ' 21 with commercial membership about 200,000 people ahead of the original outlook provided .<q>optumhealth 's revenue per consumer grew by over 30 % in ' 21 , driven by the increasing number of our patients served under value - based arrangements .<q>these ample capital capacities allow us to continue to accelerate our investments , while remaining committed to an advancing shareholder dividend and supporting our expected repurchase of between $ 5 billion and $ 6 billion of stock in ' 22 .<q>from this distance , and in contrast to the past two years , we expect the seasonal pattern to be more consistent with our historical experience , with just under 50 % of full - year earnings in the first half and the first two quarters comparably even .<q>we ended the year with a revenue backlog of $ 22.4 billion , an increase of $ 2.2 billion over the prior year .", "len_article": 19, "len_summary_gold": 3, "len_summary_pred": 8, "len_sent_scores": 19}